Klaipeda Seamen's Hospital
About Klaipeda Seamen's Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Eli Lilly and Company
3
Advanz Pharma
2
Bayer
2
Celgene
1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
1
Idorsia Pharmaceuticals Ltd.
1
InDex Pharmaceuticals
1
Intercept Pharmaceuticals
1
Renovo
1
Terumo Europe N.V.
1
Clinical Trials at Klaipeda Seamen's Hospital
During the past decade, Klaipeda Seamen's Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Juvista (Avotermin) in Scars Following Varicose Vein Removal
2006-11-01
2009-04-01
Completed
156
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
2007-03-01
2008-07-01
Completed
735
High-dose Methylprednisolone and Rituximab in High Risk B-CLL
2007-09-01
2009-12-01
Completed
29
A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation
2008-04-01
2009-11-01
Completed
254
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
2011-08-02
2016-03-25
Completed
3,080
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
2013-04-24
2023-12-31
Active, not recruiting
472
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Klaipeda Seamen's Hospital" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Eli Lilly and Company" with 3 trials
sponsored, "Advanz Pharma" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Celgene"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klaipeda Seamen's Hospital"
#1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Norwegian Health Association" with 1 trials as a collaborator, "The Royal Norwegian Ministry of Health" with 1 trials as a collaborator and "UiT The Arctic University of Norway" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Klaipeda Seamen's Hospital
According to Clinical.Site data, the most researched conditions in "Klaipeda Seamen's Hospital" are
"Ulcerative Colitis" (6 trials), "Atrial Fibrillation" (4 trials), "Acute Myocardial Infarction" (1 trials), "B-cell Lymphoma" (1 trials) and "Chronic B-Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Klaipeda Seamen's Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Klaipeda Seamen's Hospital
Most popular intervention types in "Klaipeda Seamen's Hospital" are "Drug" (19 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Etrolizumab" (2 trials), "Mirikizumab" (2 trials), "Rituximab" (2 trials) and "Adalimumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klaipeda Seamen's Hospital
The vast majority of trials in "Klaipeda Seamen's Hospital" are
21 trials for "All" genders.
Clinical Trials Status at Klaipeda Seamen's Hospital
Currently, there are NaN active trials in "Klaipeda Seamen's Hospital".
undefined are not yet recruiting,
5 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 8 completed trials in Klaipeda Seamen's Hospital,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Klaipeda Seamen's Hospital, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".